Triiodothyronine-induced Thyrotoxicosis Increases Mononuclear Leukocyte β-Adrenergic Receptor Density in Man
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 4 of the 14 sources its claims cite were checked for support.
Abstract
beta-Adrenergic receptors are increased in some tissues of experimentally thyrotoxic animals but are reported to be unchanged in mononuclear leukocytes of spontaneously thyrotoxic humans. We examined the effects of triiodothyronine (100 mug/d for 7 d) and placebo on high-affinity mononuclear leukocyte beta-adrenergic receptors in 24 normal human subjects, using a double-blind design. beta-Adrenergic receptors were assessed by specific binding of the antagonist (-)[(3)H]dihydroalprenolol. Triiodothyronine administration resulted in objective evidence of moderate thyrotoxicosis and an increase in mean (-)[(3)H]dihydroalprenolol binding from 25+/-3 to 57+/-9 fmol/mg protein (P < 0.001). The latter was attributable, by Scatchard analysis, to an increase in beta-adrenergic receptor density (967 +/- 134 to 2250 +/- 387 sites per cell, P < 0.01); apparent dissociation constants did not change. Placebo administration had no effects. Marked inter- and intraindividual variation in mononuclear leukocyte beta-adrenergic receptor density was also noted. Because this was approximately threefold greater than analytical variation, it is largely attributable to biologic variation. Thus, we conclude: (a) The finding of a triiodothyronine-induced increase in mononuclear leukocyte beta-adrenergic receptor density in human mononuclear leukocytes, coupled with similar findings in tissues of experimentally thyrotoxic animals, provides support for the use of mononuclear leukocytes to assess receptor status in man. (b) There is considerable biologic variation in beta-adrenergic receptor density in man. (c) The findings of thyroid hormone-induced increments in beta-adrenergic receptor density provide a plausible mechanism for the putative enhanced responsiveness to endogenous catecholamines of patients with thyrotoxicosis.
Overview
CoChat Summary
TL;DR
In a double-blind study of 24 normal adults, 7 days of triiodothyronine (100 μg/d) produced moderate thyrotoxicosis and increased mononuclear leukocyte β-adrenergic receptor density, while placebo had no effect. The authors conclude this provides a plausible mechanism for enhanced catecholamine responsiveness in thyrotoxicosis and supports using mononuclear leukocytes to assess receptor status in man.
Key findings
- Triiodothyronine increased specific (−)[³H]dihydroalprenolol binding from 25±3 to 57±9 fmol/mg protein (P < 0.001); placebo had no significant effect.
- Scatchard analysis attributed this to increased β-adrenergic receptor density, from 967±134 to 2,250±387 sites/cell (P < 0.01), with no change in apparent dissociation constants (1.1±0.2 to 1.1±0.3 nM).
- Triiodothyronine raised serum triiodothyronine from 145±10 to 310±20 ng/dl (P < 0.001), lowered serum thyroxine, reduced cholesterol, increased resting heart rate, and increased the heart rate–systolic blood pressure double product; plasma norepinephrine and epinephrine were not significantly altered.
- Marked inter- and intraindividual variation was noted: interindividual coefficient of variation 50%, intraindividual 58%, versus analytical variation 16%, implying biologic variation of 34–42%.
Methods
- Double-blind study of 24 normal young adults assigned alternately to triiodothyronine (25 μg four times daily for 7 days; n=12) or placebo (n=12); each subject was studied before and after treatment.
- Mononuclear leukocytes were isolated from 100 ml blood, and β-adrenergic receptors were assessed by specific binding of the antagonist (−)[³H]dihydroalprenolol, with Scatchard analysis; specific binding was defined as that displaceable by 1.0 μM (−)propranolol.
- Paired Student’s t tests compared pretreatment with post-treatment values; correlations used linear regression.
Limitations
- The paper states that experimental thyrotoxicosis from short-term exogenous thyroid hormone may be fundamentally different from long-term endogenous overproduction, and that the induced thyrotoxicosis was less severe than most spontaneous cases (1 week, no subjective manifestations, lower serum triiodothyronine).
- The paper notes that mononuclear leukocyte receptors may not reflect extravascular target tissues, and that proof of a cause–effect relationship between increased β-adrenergic receptor density and enhanced biologic responsiveness was not established.
- The paper also states that marked biologic variation may have obscured differences in prior studies comparing heterogeneous spontaneously thyrotoxic patients with controls, and that use of different (−)[³H]DHA concentrations may explain discrepant findings; evident from the text, the sample was small (12 per group) and limited to normal young adults.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 6 Not checked · 24 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Serum thyroxine concentrations declined appropriately.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was considerable inter- and intraindividual variation in mononuclear leukocyte β-adrenergic receptor density (calculated by Scatchard analysis) in the subjects studied.”
plainn = 24- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The intraindividual coefficient of variation, calculated from the determinations performed before and after placebo administration (see below), was similar, 58%.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the placebo had no significant effect on specific (-)[³H]DHA binding to mononuclear leukocyte preparations (Fig. 1).”
plainn = 12- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No significant correlations were detected between mononuclear leukocyte (-)[³H]DNA binding and basal plasma norepinephrine (r = -0.096) or epinephrine (r = 0.164) concentrations nor between binding and serum triiodothyronine (r = -0.070) or thyroxine (r = -0.207) levels in the pretreatment samples from the entire group of 24 subjects.”
plainn = 24- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 32 claims and to verify the 2 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thyroid hormone increases sensitivity to catecholamines and sensitizes beta-2 adrenergic receptors. This results in the stimulation of Na+/K+ ATPase channels in the liver and skeletal muscle allowing for potassium to move into cells [9].”
From Thyrotoxic Periodic Paralysis With Hypokalemia: A Case Study (2023) · cites this paper as [9]
Citations
Cites
Thyroid hormone regulation of beta-adrenergic receptor number.
Williams, L. T., Lefkowitz, R. J., Watanabe, A. M., Hathaway, D. R., & Besch, H. R. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40528-x · Cited by 453
Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.
Williams, L. T., Snyderman, R., & Lefkowitz, R. J. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108254 · Cited by 322
Fat cell adenylate cyclase and beta-adrenergic receptors in altered thyroid states.
Malbon, C. C., Moreno, F. J., Cabelli, R. J., & Fain, J. N. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38155-3 · Cited by 217
Plasma Noradrenaline and Adrenaline in Patients with Thyrotoxicosis and Myxoedema
Christensen, N. J. (1973) · Clinical Science · doi:10.1042/cs0450163 · Cited by 210
DAVIES, A. O., & LEFKOWITZ, R. J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-599 · Cited by 198
COULOMBE, P., DUSSAULT, J. H., & WALKER, P. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-44-6-1185 · Cited by 170
Plasma catecholamines in diabetes
Cryer, P. E., Silverberg, A. B., Santiago, J. V., & Shah, S. D. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90220-6 · Cited by 169
Self-citationCRYER, P. E., SANTIAGO, J. V., & SHAH, S. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-6-1025 · Cited by 155
Self-citationThyroxine and propylthiouracil effects in vivo on alpha and beta adrenergic receptors in rat heart
Ciaraldi, T., & Marinetti, G. V. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)91615-1 · Cited by 151
Beta adrenergic receptors in lymphocyte subpopulations
Bishopric, N. H., Cohen, H. J., & Lefkowitz, R. J. (1980) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(80)90173-6 · Cited by 148
Cited by
Adrenergic Receptors in Man: Direct Identification, Physiologic Regulation, and Clinical Alterations
Motulsky, H. J., & Insel, P. A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207013070104 · Cited by 401
Lin, S.-H. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.1.99 · Cited by 254
Thyroid–Adrenergic Interactions: Physiological and Clinical Implications
Silva, J. E., & Bianco, S. D. C. (2008) · Thyroid · doi:10.1089/thy.2007.0252 · Cited by 252
Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism
Levey, G. S., & Klein, I. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90533-j · Cited by 213
β-Adrenergic blockade for the treatment of hyperthyroidism
Geffner, D. L., & Hershman, J. M. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90681-z · Cited by 168
Use of catecholamines in pediatrics
ZARITSKY, A. L., & Chernow, B. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80003-7 · Cited by 142
Graves' disease: An analysis of thyroid hormone levels and hyperthyroid signs and symptoms
Trzepacz, P. T., Klein, I., Roberts, M., Greenhouse, J., & Levey, G. S. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80614-x · Cited by 110
Hypertension in Thyroid Disorders
Saito, I., & Samta, T. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30103-8 · Cited by 93
Hyperthyroid Myopathy and the Response to Treatment
Olson, B. R., Klein, I., Benner, R., Burdett, R., Trzepacz, P., & Levey, G. S. (1991) · Thyroid · doi:10.1089/thy.1991.1.137 · Cited by 81
Analytic review: thyrotoxic periodic paralysis: a review
Pothiwala, P., & Levine, S. N. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066609358849 · Cited by 80
“of b-receptors causing increased catecholamine-mediated potassium uptake.(23) This increase in b-adrenergic stimulation of Na-K ATPase activity may explain why stressful events may precipitate, while b-adrenergic blockers may prevent, attacks of TPP.”
Regulation of glucose metabolism by sympathochromaffin catecholamines
Clutter, W. E., Rizza, R. A., Gerich, J. E., & Cryer, P. E. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040104 · Cited by 83
Self-citationLiggett, S. B., SHAH, S. D., & Cryer, P. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113961 · Cited by 80
Self-citationLam, L., Nair, R. J., & Tingle, L. (2006) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2006.11928143 · Cited by 76
Dimitriadis, G. D., Leighton, B., Vlachonikolis, I. G., Parry-Billings, M., Challiss, R. A. J., West, D., & Newsholme, E. A. (1988) · Biochemical Journal · doi:10.1042/bj2530087 · Cited by 73
Meurs, H., van den Bogaard, W., Kauffman, H. F., & Bruynzeel, P. L. B. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90464-2 · Cited by 66
Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years
Shiang, J.-C., Cheng, C.-J., Tsai, M.-K., Hung, Y.-J., Hsu, Y.-J., Yang, S.-S., Chu, S.-J., & Lin, S.-H. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0553 · Cited by 56
Ford, H. C., & Carter, J. M. (1988) · Postgraduate Medical Journal · doi:10.1136/pgmj.64.756.735 · Cited by 53
Platelet receptor binding studies in affective disorders
Elliott, J. E. (1984) · Journal of Affective Disorders · doi:10.1016/s0165-0327(84)80001-4 · Cited by 45
Liggett, S. B., Marker, J. C., SHAH, S. D., Roper, C., & Cryer, P. E. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113600 · Cited by 51
Self-citationPsychiatric and neuropsychological response to propranolol in Graves' disease
Trzepacz, P. T., McCue, M. P., Klein, I. L., Greenhouse, J. B., & Levey, G. S. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90051-0 · Cited by 50
ROSEN, S. G., BERK, M. A., Popp, D. A., Sérusclat, P., SMITH, E. B., SHAH, S. D., Ginsberg, A. M., Clutter, W. E., & Cryer, P. E. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-6-1068 · Cited by 40
Self-citationRoti, E. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380090021007 · Cited by 40
Mladenovic, J., & Adamson, J. W. (1984) · British Journal of Haematology · doi:10.1111/j.1365-2141.1984.tb03959.x · Cited by 39
Mäki, T., KONTULA, K. K., & Härkönen, M. (1990) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519009085799 · Cited by 41
Ebstein, R. P., Oppenheim, G., Ebstein, B. S., Amiri, Z., & Tessman, J. (1986) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(86)90011-4 · Cited by 35
Mechanisms of Adrenergic and Cholinergic Regulation of Myocardial Contractility
Watanabe, A. M., & Lindemann, J. P. (1984) · Developments in cardiovascular medicine · doi:10.1007/978-1-4757-1171-4_17 · Cited by 33
Nedvidkova, J., Papežová, H., Haluzík, M., & Schreiber, V. (2000) · Endocrine Research · doi:10.3109/07435800009066163 · Cited by 34
Adrenergic Regulation of Lipolysis in Human Adipocytes: Findings in Hyper- and Hypothyroidism*
Wahrenberg, H., Engfeldt, P., Arner, P., Wennlund, A., & Östman, J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-631 · Cited by 29
Recent advances in knowledge about beta-adrenergic receptors: Application to clinical cardiology
Watanabe, A. M. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80013-8 · Cited by 29
Studies on leukocyte β-adrenergic receptors in depression: A critical appraisal
Werstiuk, E. S., Steiner, M. S., & Burns, T. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90222-d · Cited by 28
Ageing and thymus-induced differential regulation of β1 and β2 adrenoceptors of mouse brain cortex
Viticchi, C., Gentile, S., & PIANTANELLI, L. (1989) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(89)90065-4 · Cited by 27
Ebstein, R. P., Oppenheim, G., & Stessman, J. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90211-x · Cited by 26
Carter, L., Ferrari, J. K., Davison, J. S., & Befus, A. D. (1992) · Journal of Leukocyte Biology · doi:10.1002/jlb.51.6.597 · Cited by 25
Clinical Pharmacokinetics of ??-Adrenoceptor Blocking Drugs in Thyroid Disease
Feely, J. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308010-00001 · Cited by 24
Thyroid hormones and the adrenergic nervous system
Nilsson, O. R., & Karlberg, B. E. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb01610.x · Cited by 22
Fattoretti, P., Viticchi, C., & PIANTANELLI, L. (1982) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(82)90024-3 · Cited by 21
Yao, Y., Fan, L., Zhang, X., Xiao, Z., Long, Y., & Tian, H. (2013) · Thyroid · doi:10.1089/thy.2011.0493 · Cited by 19
“In TPP, this is induced by an excess of thyroid hormones (14–17) and/or b -adrenergic stimulation (18–20).”
Siddamreddy, S., & Dandu, V. (2021) · StatPearls · Cited by 26
Oppenheim, G., Mintzer, J., Halperin, Y., Eliakim, R., Stessman, J., & Ebstein, R. P. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90277-7 · Cited by 17
Changing Management Guidelines in Thyrotoxic Hypokalemic Periodic Paralysis
Correia, M. S., Darocki, M., & Hirashima, E. T. (2018) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2018.04.063 · Cited by 17
Medina, J. H., Wolfman, C., de Stein, M. L., Tumilasci, O. R., & Houssay, A. B. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90406-5 · Cited by 16
Clinical Management of Patients with Hyperthyroidism
Cooper, D. S., & Ridgway, E. C. (1985) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30999-3 · Cited by 16
Dimitriadis, G., Richards, S. J., Parry‐Billings, M., Leighton, B., Newsholme, E. A., & Challiss, R. A. J. (1991) · Biochemical Journal · doi:10.1042/bj2780587 · Cited by 14
Ebstein, R. P., Oppenheim, G., Zlotogorski, Z., van Dijk, Y., Doron, A., & Stessman, J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90348-6 · Cited by 14
Thyroid status affects the rat cardiac β‐adrenoceptor system transiently and time‐dependently
Zwaveling, J., Batink, H. D., Taguchi, K., de Jong, J., Michel, M. C., Pfaffendorf, M., & van Zwieten, A. (1998) · Journal of Autonomic Pharmacology · doi:10.1046/j.1365-2680.1998.1810001.x · Cited by 13
Sekiguchi, Y., Hara, Y., Takahashi, M., & Hirata, Y. (2005) · PubMed · Cited by 13
Beta-Adrenergic Receptors in Pathophysiologic States and in Clinical Medicine
Insel, P. A. (1991) · Humana Press eBooks · doi:10.1007/978-1-4612-0463-3_7 · Cited by 14
Centrophenoxine-induced increase of beta-adrenoceptor density in brain cortex of old mice
Viticchi, C., Gentile, S., & PIANTANELLI, L. (1984) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(84)90017-7 · Cited by 12
Unaltered glucose-induced thermogenesis in Graves’ disease
Randin, J. P., Schutz, Y., Scazziga, B., Lemarchand-Béraud, T., Jp, F., & Jéquier, E. (1986) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/43.5.738 · Cited by 11
Clinical and Biochemical Responses to Nadolol and Clonidine in Hyperthyroidism
Herman, V., Joffe, B. I., Kalk, W. J., Panz, V. R., Wing, J., & Seftel, H. C. (1989) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1989.tb03288.x · Cited by 11
Impaired adaptive receptor regulation: an index of aging?
PIANTANELLI, L., Viticchi, C., Fattoretti, P., & Basso, A. (1986) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(86)90035-x · Cited by 10
Leirós, C. P., & Borda, E. (1986) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(86)90124-4 · Cited by 10
Cardiovascular β-adrenoceptor sensitivity of undernourished subjects
Jayarajan, M. P., & Shetty, P. S. (1987) · British Journal Of Nutrition · doi:10.1079/bjn19870063 · Cited by 11
Parálisis períodica hipocalcémica tirotóxica
Pinzón, A., & Vásquez, N. (2014) · Revista Med · doi:10.18359/rmed.1032 · Cited by 10
Allard, M., Barrallier, M., Pisaroni, H., Fichet, M., De La Vergne De Cerval, M., Pflaum, R., Poisson, A., Derrien, C., Bonnet, F., & Vaduva, P. (2023) · Annales d'Endocrinologie · doi:10.1016/j.ando.2023.01.007 · Cited by 9
Disease, Metabolism and Reproduction in the Toxic Response to Drugs and Other Chemicals
Chambers, P. L., Preziosi, P., & Chambers, C. M. (1984) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-69132-4 · Cited by 9
Fisher, B. M., Smith, J. G., McCruden, D. C., & Frier, B. M. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb01237.x · Cited by 9
Mechanisms of Adrenergic and Cholinergic Regulation of Myocardial Contractility
Lindemann, J. P., & Watanabe, A. M. (1989) · Developments in cardiovascular medicine · doi:10.1007/978-1-4613-0873-7_20 · Cited by 8
Tsai, M., Lin, S., Leu, J., & Fang, Y. (2015) · Medicine · doi:10.1097/md.0000000000001689 · Cited by 9
“Moreover, thyroid hormone has a similar chemical structure to that of catecholamines, which can directly activate the Naþ-Kþ-ATPase pump and concurrently increase the number and sensitivity of b-receptors.(9) Chronic alcoholism is usually associated with electrolyte abnormalities and metabolic alkalosis.”
BackgroundBilezikian, J. P., & Loeb, J. N. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90282-x · Cited by 8
Thyrotoxic Hypokalemic Periodic Paralysis: Six Cases in Non-Asian Patients
Gordon, D. L., Agrawal, L., Swade, T. F., & Lawrence, A. M. (1998) · Endocrine Practice · doi:10.4158/ep.4.3.142 · Cited by 8
Influence of Hyper- and Hypothyroidism on Subcutaneous Adipose Tissue Blood Flow in Man*
Wennlund, A., & Linde, B. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-2-258 · Cited by 7
Lin, Y.-Y., & Hsieh, Y.-S. (2021) · Cureus · doi:10.7759/cureus.15880 · Cited by 6
“Hyperthyroidism can induce hyperadrenergic conditions by a chemical structure similar to that of catecholamines, activation of Na+/K+ ATPase, and increase of the sensitivity of ꞵ-receptors [18,19].”
BackgroundThe effect of theophylline on thyrotoxic tremor.
Buss, D., Phillips, D. I., Littley, M. D., Marshall, R. W., Routledge, P., & Lazarus, J. H. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03511.x · Cited by 6
Drug Toxicity and Hormonal Dysfunction
Eichelbaum, M. F. (1984) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-69132-4_4 · Cited by 6
Mechanisms of enhanced phosphorylase activation in the hyperthyroid rat heart
Werth, D. K. (1983) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(83)90296-1 · Cited by 6
The effect of in vitro procedures on cyclic AMP accumulation in human leucocytes
Johansen, T., Friis, U. G., Rasmussen, A. K., & Foged, N. (1994) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519409086519 · Cited by 6
Hypoglycaemia: glucose counterregulation, cardiovascular responses and immunoregulation
Cryer, P. E. (1983) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1983.tb00055.x · Cited by 5
Self-citationEbstein, R. P., Mintzer, J., Lipschitz, Y., Shemesh, Z., & Stessman, J. (1986) · Cellular and Molecular Life Sciences · doi:10.1007/bf01941546 · Cited by 5
A Case of Thyrotoxic Periodic Paralysis in Adolescent with Graves' Disease
Oh, K. W., Jeong, J. Y., & Kim, J. S. (2011) · Journal of Korean Society of Pediatric Endocrinology · doi:10.6065/jkspe.2011.16.3.196 · Cited by 4
Rosenqvist, U., & Hylander, B. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90280-6 · Cited by 4
Determination of beta adrenoceptor density on rabbit mononuclear leukocytes
Earley, K. J., Gunasegaram, S., & Tenner, T. E. (1988) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(88)90021-6 · Cited by 4
Thyrotoxic Periodic Paralysis With Hypokalemia: A Case Study
Mebane, N. B., Khan, A., Bevinal, M., & Davis, E. (2023) · Cureus · doi:10.7759/cureus.40757 · Cited by 3
“This results in the stimulation of Na+/K+ ATPase channels in the liver and skeletal muscle allowing for potassium to move into cells [9].”
BackgroundThyroid hormone-induced up-regulation of β1- and β2-adrenergic receptors during aging
Viticchi, C., Basso, A., Zaia, A., & PIANTANELLI, L. (1992) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(05)80038-x · Cited by 3
Adrenergic receptors are a fallible index of adrenergic denervation hypersensitivity
Dejgaard, A., Liggett, S. B., Ristensen, N. J. C., Cryer, P. E., & Hilsted, J. (1991) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519109104578 · Cited by 3
Self-citationThe relevance of advances in receptor pharmacology to clinical cardiologye
Coupe, M. O., & Clarke, B. (1988) · International Journal of Cardiology · doi:10.1016/0167-5273(88)90232-x · Cited by 3
Furukawa, H., Loeb, J. N., & Bilezikian, J. P. (1982) · Endocrinology · doi:10.1210/endo-111-6-1891 · Cited by 3
Ratge, D., Hansel, S., & Wisser, H. (1984) · Fresenius Zeitschrift für Analytische Chemie · doi:10.1007/bf00593868 · Cited by 3
The human lymphocyte as a model of β-adrenoceptor reculation in aging and disease
Basso, A., Rossolini, G., Viticchi, C., Zaia, A., & Plantanelli, L. (1992) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(05)80005-6 · Cited by 2
Exploring the enigma of thyrotoxic periodic paralysis: A complex interplay of hormones and muscles
Podimon, J., Rahim, S. A., Sarojiniamma, C., Philip, R., Dev, D. A., & Khadir, C. A. (2024) · Thyroid Research and Practice · doi:10.4103/trp.trp_10_24 · Cited by 3
Ecstasy-induced thyrotoxic periodic paralysis
Forrest, L., & Platts, J. K. (2009) · BMJ Case Reports · doi:10.1136/bcr.09.2009.2280 · Cited by 2
Effect of β-blockade and subsequent triiodothyronine administration on human leucocyte Na-K ATPase
Turaihi, K. S., Perelman, M., Baron, D. N., & Dandona, P. (1988) · Metabolism · doi:10.1016/0026-0495(88)90053-4 · Cited by 2
Beta-adrenoceptor involvement in tremor production: possible defects in essential tremor
Kilfeather, S., Massarella, A., Turner, P. P., & Findley, L. J. J. (1984) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-06757-2_16 · Cited by 2
Thyroid Hormone Actions: To Be ta or Not to Be ta
Mariash, C. N. (2010) · Thyroid · doi:10.1089/thy.2010.1630 · Cited by 2
Respiratory Failure in Hyperthyroidism: Focus on Thyrotoxic Periodic Paralysis
Tun, T., Htay, W. Y., & Myat, K. (2025) · Cureus · doi:10.7759/cureus.90200 · Cited by 2
“Thyroid hormones also upregulate both the density and sensitivity of β - adrenergic receptors, amplifying catecholamine-driven potassium uptake [10].”
Lee, J. D., You, M. H., Kim, Y. S., Kim, J. W., Kim, K. W., Kim, S. W., & Choi, Y. K. (1986) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.1986.1.1.78 · Cited by 1
An Unusual Cause of Muscle Weakness: A Case Report
Gandhi, M. (2006) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200609000-00007 · Cited by 1
Lefkowitz, R. J. (1983) · PubMed · Cited by 1
Robertson, D., Parfyonova, Y. V., Menshikov, M. Y., & Hollister, A. S. (1989) · Springer eBooks · doi:10.1007/978-1-4899-0906-0_14 · Cited by 1
Dong, B. J. (1992) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-13175-4_71 · Cited by 1
Case Studies in Electrolyte and Acid–Base Disorders
Mount, D. B. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3770-3_12
3H-ouabain binding to human mononuclear leucocytes
Ludwig, K., Brown, L., & Erdmann, E. (1985) · Journal of Molecular Medicine · doi:10.1007/bf01739676
Hiatt, W. R., Travis, V. L., Horwitz, K. B., & Horwitz, L. D. (1985) · Journal of Receptor Research · doi:10.3109/10799898509041891
Noji, T. (1986) · Kitakantou igaku/Kitakantō Igaku · doi:10.2974/kmj1951.36.39
Gutch, M., Shakya, S., Bhattacharjee, A., Manjari, D., & Pushkar, D. (2016) · MAMC Journal of Medical Sciences · doi:10.4103/2394-7438.191694
Studies on the β-Adrenergic Receptor: Clinical and Basic Implications
Seidman, C. E., & Homcy, C. J. (1984) · Clinics in Anaesthesiology · doi:10.1016/s0261-9881(21)00177-4
Woeber, K. A., & Braverman, L. E. (1985) · Springer eBooks · doi:10.1007/978-1-4684-4817-7_3
Thyrotoxic Periodic Paralysis after Surgery: A Case Report and Literature Review
Wouters, C., Willems, M., Mullens, A., & Meersman, A. (2023) · Emergency Medicine - Open Journal · doi:10.17140/emoj-9-172
Donor conditioning in organ procurement
Novitzky, D. (1997) · Springer eBooks · doi:10.1007/978-94-011-5422-2_8
Metadata
- Authors
- Ginsberg, A. M., Clutter, W. E., Shah, S. D., & Cryer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Ginsberg, Ann M.
- Venue
- Journal of Clinical Investigation
- Published
- 1981-06-01
- Volume
- 67
- Issue
- 6
- Pages
- 1785-1791
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC370757
- OpenAlex
- W2145338884
- Cited by
- 99
- References
- 38
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2021: 2 · 2018: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- thyrotoxicosis, triiodothyronine, beta-adrenergic receptors, mononuclear leukocytes, receptor density, dihydroalprenolol binding, thyroid hormones, catecholamine responsiveness, interindividual variability
- MeSH terms
- Adult, Binding Sites, Blood Cell Count, Blood Pressure, Catecholamines, Double-Blind Method, Female, Heart Rate, Humans, Hyperthyroidism, Male, Monocytes, Receptors, Adrenergic, Receptors, Adrenergic, beta, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.